Clinical Study To Evaluate The Effect Of Pradar Nashak Yoga In Pittaja Asrugdar (AUB-O).
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Improvement in sign and symptoms of pittaja asrugdar.
研究概览
简要总结
Abnormal uterine bleeding (AUB) is a common condition that affects 10–30% of women of reproductive age group. Up to one-third of women experience AUB in their lifetime.AUB can cause significant morbidity and negatively impact a woman’s physical, social, emotional, and material quality of life. Hence It is time to investigate and construct a clinically and scientifically abnormal uterine bleeding management strategy that is not only cost effective. Chronic AUB can lead to severe Anemia, Infertility & Endometrial cancer. hence, it is need of the hour to treat this disease in time, so that these complications can be avoided and women can lead a healthy life. In modern medicine Hemostatic, Analgesic and Hormonal therapies are advised for abnormal uterine bleeding. Their side effects have led to hormonal imbalances hence it is need of time to have an integrated and comprehensive therapeutic intervention in Ayurveda to prevent recurrence & would overcome thelimitations of modern medicine.
In this study we choose Pradar nashak yoga which contains Yastimadhu Haritaki Amalaki Vibhitaki Lodhr Motha,and Sphatik Madhu as Anupaana which stop the bleeding per vagina . In Ayurvedic classics drugs and formulations which have property of Kashaya and Tikta rasa Sheeta veerya Katu Vipaka Shothahara Grahi Garbhashaya Balya Rakta shodhaka Rakta-stambhana and Vatanulomana properties are described for the treatment of Asrugdar.
A clinical study will be conducted to see the efficacy of Pradar Nashak Yoga in pittaja asrugdar (AUB-O).At first, all participants will be screened to check their eligibility for the study. A total of 30 clinically diagnosed patients will be enrolled in this study after taking informed written consent. After that, the first assessment will be done before drug administration with a validated questionnaire and grading will be done according to the signs and symptoms of the patients. Then the drug therapy will be started and the total duration will be 60 days.Two follow ups will be done each after 30 days. The last assessment will be done on the 60th day and the grading will be given again to see the changes in the signs and symptoms of pittja asrugdar.Signatures on informed consent and patient information sheets will be taken on hard copy, and all other relevant data for the study will be collected. After the collection of all the relevant data, the analysis of the data will be done.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- Female
入选标准
- •1.Duration of bleeding more than 7 days 2.Amount of blood loss more than 80 ml of menstrual bleeding.
排除标准
- •1.Age less than 20 years and above 50 years.
- •2.Hb less than 8 gm per dl.
- •3.Patient diagnosed with diabetes hypertension thyroid tuberculosis human immunodeficiency virus.
- •4.Patient diagnosed with any systemic illness or taking blood thinning medicine.
结局指标
主要结局
Improvement in sign and symptoms of pittaja asrugdar.
时间窗: 1st day,last day of first menstrual period after intervention period, last day second menstrual period after intervention period.
次要结局
- 1.Improvement of quality of life.(2.Duration of bleeding less than 7 days.)
研究者
Dr Sudha Gupta
Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre
